: Why a pill you take at home could change the direction of the pandemic
Merck and Ridgeback Biotherapeutics’ promising oral antiviral could shift the direction of the pandemic by making it easier for people with COVID-19 to take a pill at home that can keep them from getting severely sick.
Merck’s MRK stock gained 9.1% in trading on Friday after announcing that the drug, molnupiravir, cut the risk of hospitalization or death by 50% in a Phase 3 clinical trial. (Ridgeback is privately held.)
What's your reaction?